Tyler Moyer, Senior Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc.

Tyler Moyer

Senior Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. | Boston, Massachusetts, United States

Profile last verified June 2026
Biotechnology Verified Profile Boston, Massachusetts, United States The Johns Hopkins University School of Medicine
Verified

Personal Email

***@gmail.com

Personal • High Confidence

Phone Number

570*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Tyler Moyer Socials
Tyler Moyer Work Experience

Senior Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. in January 2023 - Present

Scientist II, Novel Capsid Discovery at Voyager Therapeutics, Inc. in July 2021 - December 2022

Scientist I, Novel Capsid Discovery at Voyager Therapeutics, Inc. in June 2019 - June 2021

See more See less

PHD Candidate, NSF Graduate Research Fellow at The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics in June 2013 - May 2019

Graduate Intern at AstraZeneca in February 2019 - April 2019

Field Executive at Chi Phi Fraternity in June 2012 - June 2013

Science Teacher at Pine Bluff Public Schools in August 2011 - May 2012

Tyler Moyer Education

The Johns Hopkins University School of Medicine, January 2013 to January 2019

Bucknell University, January 2007 to January 2011

Tyler Moyer Skills
Molecular Biology Biochemistry Cell Culture Cell Biology Polymerase Chain Reaction (PCR) Western Blotting Science Life Sciences Genetics Fluorescence Microscopy Molecular Cloning Protein Chemistry Data Analysis RNAi Protein Expression and Purification (bacterial, insect, mammalian) CRISPR genome editing Protein Purification Protein Expression Gene Editing Flow Cytometry Confocal Microscopy Public Speaking Microscopy Microsoft Office Research Tissue Culture
About Tyler Moyer’s Current Company
Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc. (Nasdaq: VYGR) is a biotechnology company dedicated to leveraging the power of human genetics to modify the course of – and ultimately cure – neurological diseases. Our pipeline includes programs for Alzheimer’s disease, Friedreich’s ataxia, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and multiple other diseases of the central nervous system. Many of our programs are derived from our TRACER™ AAV capsid discovery platform, which we have used to generate novel capsids and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous dosing. Some of our programs are wholly owned, and some are advancing with partners including Alexion, AstraZeneca Rare Disease; Novartis Pharma AG; and Neurocrine Biosciences, Inc. For more information, visit www.voyagertherapeutics.com. Voyager Therapeutics® is a registered trademark, and TRACER™ is a trademark, of Voyager Therapeutics, Inc.

Discover more about Voyager Therapeutics, Inc.
Tyler Moyer’s Colleagues
Dorothy Griffiths

Dorothy Griffiths

Cambridge, Massachusetts, United States

Sr. Executive Assistant at Voyager Therapeutics, Inc.

Sr. Executive Assistant at Voyager Therapeutics, Inc.
(May 2018 – Present)

Mahdiar Khakinejad

Mahdiar Khakinejad

Cambridge, Massachusetts, United States

Senior Scientist | Biophysics & Analytical Chemistry Expert | Mass Spectrometry, Chromatography & Protein Characterization Specialist

Senior Scientist at Voyager Therapeutics, Inc.
(Sep 2025 – Present)

Toby Ferguson

Toby Ferguson

Greater Boston

Chief Medical Officer @ Voyager Therapeutics |

Chief Medical Officer at Voyager Therapeutics, Inc.
(Mar 2024 – Present)

Sindhu Velmurugan

Sindhu Velmurugan

Cambridge, Massachusetts, United States

In-Vivo Scientist | Gene Therapy & Neuroscience | Huntington’s Disease | AAV, Rodent Models| Voyager Therapeutics

Promoted to lead expanded in-vivo research responsibilities for gene therapy programs targeting neurodegenerative diseases.

- Leading CNS gene therapy studies from study design through execution and analysis, supporting IND-enabling work
- Driving cross-functional collaborati...

Brett Noel

Brett Noel

United States

Senior Director, Corporate and Business Development at Voyager Therapeutics

Senior Director, Corporate and Business Development at Voyager Therapeutics, Inc.
(May 2025 – Present)

Jeron Chen

Jeron Chen

Boston, Massachusetts, United States

Head of Data Science and Payload Innovation

Leading the machine learning, bioinformatics, and payload engineering teams to advance next-generation gene and protein platform technologies (AAV capsids and antibodies).

Building biological platform tools including regulatable expression systems, tissue-specific promoters, ...

Search similar profiles
Frequently asked questions about Tyler Moyer

What is Tyler Moyer email address?

Email Tyler Moyer at [email protected]. This email is the most updated Tyler Moyer's email found in 2026.

How to contact Tyler Moyer?

To contact Tyler Moyer send an email to [email protected].

What company does Tyler Moyer work for?

Tyler Moyer works for Voyager Therapeutics, Inc..

What is Tyler Moyer's role at Voyager Therapeutics, Inc.?

Tyler Moyer is Senior Scientist I, Novel Capsid Discovery

What industry does Tyler Moyer work in?

Tyler Moyer works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free